ARWR R&D to Revenue
Arrowhead Pharmaceuticals Inc · R&D to Revenue
ARWR R&D to Revenue
Latest reported73.20%period ending
ARWR FY R&D/Revenue (0.00% → 73.20%)
Latest values, visible window
High-resolution chart · PNG
ARWR r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 73.2004% | |
| 13,776.8516% | |
| 142.1945% | |
| 118.6115% | |
| 149.2129% | |
| 140.4034% | |
| 45.3971% | |
| 299.1901% | |
| 147.2633% | |
| 26,181.8143% | |
| 12,373.6547% | |
| 13,221.7429% | |
| 2,999.1894% | |
| 3,670.7833% | |
| 1,106.8316% | |
| 138.2701% | |
| 165.1654% | |
| 637.6266% | |
| 905.252% | |
| 1,441.2467% | |
| 642.2018% | |
| 404.1415% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |